GlobalData on MSN12h
AstraZeneca secures first BTK approval in first-line mantle cell lymphomaThe approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.
ShareA translational biomedical research hub in Nigeria, Helix Biogen Institute (HBI) has appointed Emmanuel Adediran as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback